The ISSCR is pleased to announce Keith Alm will today assume the role of CEO. He replaces retiring Nancy Witty, after 16 years of leadership.
Alm joined the ISSCR as COO in January 2019 after serving as a strategist and consultant for the society for nearly a decade. In the past year, Alm has been a driving force behind the society’s digital transformation, working closely with the Board of Directors to introduce new scientific education programs and technology initiatives to meet the needs of the ISSCR’s global membership.
“On behalf of the entire Board of Directors, I am so pleased to welcome Keith to the role of CEO,” said ISSCR President Melissa H. Little, PhD, Murdoch Childrens Research Institute and University of Melbourne, Australia. “His strategic leadership is an asset to our society as we adapt to address the evolving needs of our international community and continue thrive as the world’s leading international society dedicated to stem cell research and regenerative medicine.”
Alm was introduced to the ISSCR in 2008 while serving as a Vice President with global PR and marketing firm FleishmanHillard (FH). During his 11-year tenure with the firm, he led integrated marketing and public affairs campaigns across a variety of industries including the healthcare and nonprofit sectors. He later led the Washington, DC business development practice as senior vice president and partner. Alm holds an MBA from the University of Maryland with a focus on international strategy, and a BA from Wake Forest University.